MASSDEVICE ON CALL — Initial public offerings in the medical device sector raised half as much during the fiscal year that ended in June as they did during the previous year, a new report found.
The lull is likely related to ever-growing gap between the biggest and smallest companies in the industry, a disparity that has "closed and locked" the IPO opportunity for young firms, according to an analysis from the accounting firm Ernst & Young.
Medical device IPOs in fiscal 2013 raised 52% less than in the previous year, down about 80% from levels seen before 2009, according to the Boston Business Journal.
SF hospital in the spotlight after missing patient turns up in stairwell
A patient who wandered off during treatment was found dead in a San Francisco General Hospital stairwell after more than 2 weeks missing, prompting hospital officials and healthcare regulators to review the facility’s alarms, monitoring and other safety measures.
Read more
National advisory hasn’t stemmed routine prostate cancer screening
Even though no medical organizations now back prostate-specific antigen screening for men over 75, more than 40% of U.S. men still get the tests on recommendation from their primary care physicians.
Read more
Boston diabetes accelerator born from VCs and non-profits
Investment firm PureTech Ventures joined forces with JDRF (formerly the Juvenile Diabetes Research Foundation) to launch T1D Innovations, a Boston-based startup incubator the innovations that help patients suffering from Type I diabetes.
Read more
Small study doubts the benefits of transvaginal mesh
Transvaginal mesh, a device in the spotlight amid hundreds of patient injury lawsuits, may not do much for women suffering from vaginal prolapse, according to the Life Care Solutions Group, sharing findings from a 65-patient study that it says found no difference in 3-year cure rates for women treated with and without the surgical mesh.
Read more
